Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2016. 29 of 30 entries say "Materialised", first in FY2017-Q2. Latest entry: FY2025.
OPTiM moved to the "Worse" side of this theme in 2016, 4 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- FY2025MaterialisedAnnual report
「1 April 2024–31 March 2025 35,296 55,198,528 847 445,435 847 409,935 (Note) Increase due to the exercise of stock acquisition rights.」
In FY2025, 35,296 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital surplus by ¥847 thousand, respectively. - FY2025-H1MaterialisedAnnual report
「1 April 2024–30 September 2024 (Note) 35,296 55,198,528 847 445,435 847 409,935 (Note) Increase due to the exercise of stock acquisition rights.」
During the interim consolidated accounting period, 35,296 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital surplus by ¥847 thousand, respectively. - FY2024-Q3MaterialisedAnnual report
「1 October 2023–31 December 2023 (Note) 1 2,368 55,150,848 56 444,290 56 408,790 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. From 1 January to 31 January 2024, the total number of issued shares increased by 12,384 through the exercise of stock acquisition rights, while stated capital and the capital surplus each increased by ¥297 thousand.」
In the third quarter, 2,368 shares were issued through the exercise of stock acquisition rights, and a further 12,384 shares were issued in January 2024. - FY2024-Q2MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 1 1,696 55,148,480 40 444,233 40 408,733 (Note) 1. Increase due to the exercise of stock acquisition rights.」
In the second quarter, 1,696 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital surplus by ¥40 thousand, respectively. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 1 2,816 55,146,784 67 444,193 67 408,693 (Note) 1. Increase due to the exercise of stock acquisition rights.」
In the first quarter, 2,816 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital surplus by ¥67 thousand, respectively. An additional increase of 1,696 shares in July 2023 is also reported. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 1 2,656 55,143,680 63 444,118 63 408,618 (Note) 1. Increase due to the exercise of stock acquisition rights.」
In the third quarter, 2,656 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital surplus by ¥63 thousand, respectively. - FY2023-Q2MaterialisedAnnual report
「Common stock 55,141,024 55,143,680」
The number of issued shares increased from 55,141,024 as of 30 September 2022 to 55,143,680 as of the filing date. The filing also states that shares issued through the exercise of stock acquisition rights from 1 November 2022 onward are not included in the number as of the filing date. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 1,504 55,141,024 36 444,054 36 408,554 (Note) Increase resulting from the exercise of share acquisition rights.」
In the first quarter, 1,504 shares were issued through the exercise of stock acquisition rights, increasing both stated capital and the capital surplus by ¥36 thousand, respectively. - FY2022MaterialisedAnnual report
「The increase of 11,232 in the total number of issued common shares resulted from the exercise of stock options.」
During the period, 11,232 shares were issued through the exercise of share acquisition rights, resulting in an increase in the number of shares. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 1 7,584 55,138,272 182 443,988 182 408,488 (Note) 1. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 7,584 in the third quarter through the exercise of share acquisition rights, followed by a further increase of 1,248 shares by the filing date. - FY2022-Q2MaterialisedAnnual report
「1 July 2021–30 September 2021 (Note) 1 1,216 55,130,688 29 443,806 29 408,306 (Note) 1. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 1,216 in the second quarter through the exercise of share acquisition rights, and both capital and capital reserves increased by ¥29 thousand. - FY2022-Q1MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) 1 1,184 55,129,472 28 443,777 28 408,277 (Note) 1. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 1,184 in the first quarter through the exercise of share acquisition rights, and both capital and capital reserves increased by ¥28 thousand. - FY2021MaterialisedAnnual report
「1 April 2020–31 March 2021 12,928 55,128,288 310 443,749 310 408,249 (Note) Increase resulting from the exercise of share acquisition rights.」
During the period, the number of shares increased by 12,928 through the exercise of share acquisition rights, and the number of issued shares, capital and capital reserves increased. - FY2021-Q3MaterialisedAnnual report
「1 October 2020–31 December 2020 (Note) 1,280 55,128,288 30 443,749 30 408,249 (Note) Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 1,280 in the third quarter through the exercise of share acquisition rights, and both capital and capital reserves increased by ¥30 thousand. - FY2021-Q2MaterialisedAnnual report
「1 July 2020–30 September 2020 (Note) 1 1,408 55,127,008 33 443,718 33 408,218 (Note) 1. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 1,408 in the second quarter through the exercise of share acquisition rights, followed by a further increase of 1,280 shares by the filing date. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 10,240 55,125,600 245 443,684 245 408,184 (Note) 2. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 10,240 in the first quarter through the exercise of share acquisition rights, and both capital and capital reserves increased by ¥245 thousand. A further increase of 1,408 shares by the filing date was also reported. - FY2020MaterialisedAnnual report
「Funds generated from financing activities amounted to ¥250 thousand. This was attributable to proceeds of ¥250 thousand from the issuance of shares through the exercise of share acquisition rights.」
In the fiscal year ended March 2020, the number of shares increased by 2,608 through the exercise of share acquisition rights, generating proceeds of ¥250 thousand from the issuance of shares. - FY2020-Q3MaterialisedAnnual report
「1 October 2019–31 December 2019 (Note) 1,264 27,557,072 60 443,409 60 407,909 (Note) 1. Increase resulting from the exercise of share acquisition rights. 2. Between 1 January 2020 and 31 January 2020, the total number of issued shares increased by 608 and both capital and capital reserves increased by ¥29 thousand through the exercise of share acquisition rights.」
The number of shares increased by 1,264 in the third quarter through the exercise of share acquisition rights, followed by a further increase of 608 shares by the filing date. - FY2020-Q2MaterialisedAnnual report
「1 July 2019–30 September 2019 736 27,555,808 35 443,349 35 407,849 (Note) 1. Increase resulting from the exercise of share acquisition rights. 2. Between 1 October 2019 and 31 October 2019, the total number of issued shares increased by 1,264 and both capital and capital reserves increased by ¥60 thousand through the exercise of share acquisition rights.」
The number of shares increased by 736 in the second quarter through the exercise of share acquisition rights, followed by a further increase of 1,264 shares by the filing date. - FY2019MaterialisedAnnual report
「1 April 2018–31 March 2019 3,416 13,777,536 327 443,313 327 407,813 (Note) Increase resulting from the exercise of share acquisition rights.」
During the period, the number of shares increased by 3,416 through the exercise of share acquisition rights. - FY2019-Q3MaterialisedAnnual report
「1 October 2018–31 December 2018 (Note) 2,832 13,777,536 271 443,313 271 407,813 (Note) Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 2,832 in the third quarter through the exercise of share acquisition rights, and the increase in shares continued. - FY2019-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares increased by 208 in the second quarter through the exercise of share acquisition rights, followed by a further increase of 2,832 shares by the filing date. - FY2019-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The number of shares increased by 376 in the first quarter through the exercise of share acquisition rights, followed by a further increase of 208 shares by the filing date. - FY2018MaterialisedAnnual report
「The increase of 7,110,452 in issued common shares comprised an increase of 6,663,668 shares from a stock split and an increase of 446,784 shares from the exercise of stock options.」
During the period, 446,784 shares were issued through the exercise of share acquisition rights, resulting in an increase in the number of shares from the exercise of potential shares. - FY2018-Q3MaterialisedAnnual report
「1 October 2017–31 December 2017 (Note) 1 14,400 13,344,416 813 418,671 813 383,171 (Note) 1. Increase resulting from the exercise of share acquisition rights. 2. Between 1 January 2018 and 31 January 2018, the total number of issued shares increased by 95,304 and both capital and capital reserves increased by ¥5,420 thousand through the exercise of share acquisition rights.」
The number of shares increased by 14,400 in the third quarter through the exercise of share acquisition rights, followed by a further increase of 95,304 shares by the filing date. - FY2018-Q2MaterialisedAnnual report
「1 July 2017–30 September 2017 2,184 13,330,016 146 417,858 146 382,358 (Note) 1. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 2,184 in the second quarter through the exercise of share acquisition rights, and the increase in shares continued. - FY2018-Q1MaterialisedAnnual report
「1 April 2017–30 June 2017 496 13,327,832 47 417,711 47 382,211 (Note) 2. Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 496 in the first quarter through the exercise of share acquisition rights, and the increase in shares continued. - FY2017-Q3MaterialisedAnnual report
「1 October 2016–31 December 2016 (Note) 38,272 6,663,500 4,486 417,632 4,486 382,132 (Note) Increase resulting from the exercise of share acquisition rights.」
The number of shares increased by 38,272 in the third quarter through the exercise of share acquisition rights, and the increase in shares from the exercise of potential shares continued. - FY2017-Q2MaterialisedAnnual report
「Change in total number of issued shares (shares): 13,628. This increase resulted from the exercise of share acquisition rights.」
The issuance of 13,628 shares through the exercise of share acquisition rights actually occurred, potentially resulting in dilution of the value of the shares outstanding. - FY2016First statedAnnual report
「As of 31 May 2016, the number of potential shares associated with these share acquisition rights was 330,972, equivalent to 5.0% of the total 6,611,600 issued shares.」
The Company discloses the potential dilution of existing shareholders' value and voting rights from the exercise of share acquisition rights granted to directors, officers and employees.